Question 1

What are the potential benefits of adding tocilizumab to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis clinical trial (NCT01211834). Contact the study team or your healthcare provider for specific answers.

Question 2

How does tocilizumab compare to my current medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis clinical trial (NCT01211834). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from tocilizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis clinical trial (NCT01211834). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and check-ups?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis clinical trial (NCT01211834). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific tests I need to undergo before starting this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis clinical trial (NCT01211834). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I don't respond well to tocilizumab?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis clinical trial (NCT01211834). Contact the study team or your healthcare provider for specific answers.

What this study is about